tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Scott Henry, 124 are a BUY (86.71%), 19 are a HOLD (13.29%).
Analyst Scott Henry, currently employed at ALLIANCE GLOBAL PARTNERS, carries an average stock price target met ratio of 56.62% that have a potential upside of 57.23% achieved within 403 days. Previously, Scott Henry worked at ROTH MKM.
Scott Henry’s has documented 294 price targets and ratings displayed on 42 stocks. The coverage is on Healthcare, Financial Services, Utilities, Industrials sectors.
Most recent stock forecast was given on VVOS, Vivos Therapeutics at 19-Nov-2024.
Analyst best performing recommendations are on INVO (INVO BIOSCIENCE).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $125 was fulfilled within 1 day with a profit of $12.64 (11.25%) receiving and performance score of 112.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Feb-2023
$119
$46.71 (64.61%)
$124
2 months 12 days ago
(10-Aug-2026)
7/12 (58.33%)
$43.24 (57.07%)
320
Hold Since 17-Jul-2026
$90
$17.71 (24.50%)
$91
2 months 12 days ago
(10-Aug-2026)
0/2 (0%)
$14.24 (18.80%)
Buy Since 11-Dec-2024
$103
$30.71 (42.48%)
$100
1 years 7 days ago
(15-Oct-2025)
2/4 (50%)
$12.9 (14.32%)
202
Hold Since 22-Oct-2024
$90
$17.71 (24.50%)
$77
1 years 13 days ago
(09-Oct-2025)
13/13 (100%)
$-0.78 (-0.86%)
298
Buy Since 12-Mar-2025
$115
$30.5 (36.09%)
$85
1 years 28 days ago
(24-Sep-2025)
1/2 (50%)
$20.01 (21.07%)
153
What Year was the first public recommendation made by Scott Henry?
